Success Metrics

Active Trials

2(40%)

Phase Distribution

Ph early_phase_1

20%

Ph phase_3

20%

Ph not_applicable

40%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 1Safety & dosage

1(20.0%)

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Other(1)

Detailed Status

Active, not recruiting2

Enrolling by invitation1

unknown1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (20.0%)

Phase 11 (20.0%)

Phase 31 (20.0%)

N/A2 (40.0%)

Trials by Status

active_not_recruiting240%

enrolling_by_invitation120%

unknown120%

not_yet_recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

active_not_recruitingphase_3

Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

NCT05714904

Clinical Trials (5)

Showing 5 of 5 trials

NCT06743646Phase 3

Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Active Not Recruiting

NCT07307469Not Applicable

Compassionate Administration of ZVS101e for Extended Treatment

Enrolling By Invitation

NCT05832684Phase 1

Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Active Not Recruiting

NCT07653971Not Applicable

ZVS101e in Patients With Bietti's Crystalline Dystrophy

Not Yet Recruiting

NCT05714904Early Phase 1

Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5